Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaydira Del Rivero

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Oncology (Williston Park, N.Y.)|April 17, 2017
PARP Inhibitors: The Cornerstone of DNA Repair-Targeted TherapiesJaydira del Rivero, Elise C Kohn
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 13, 2015
Invited commentaryJaydira Del Rivero, Steven K Libutti
JAMA Oncology|November 8, 2019
Neuroendocrine Tumors-Less Well Known, Often Misunderstood, and Rapidly Growing in IncidenceAman Chauhan, Elise Kohn, Jaydira Del Rivero
Translational Lung Cancer Research|February 3, 2017
Metastatic lung cancer in the age of targeted therapy: improving long-term survivalJaydira Del Rivero, Lindsey Enewold, Anish Thomas
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 16, 2010
Visual vignette. Ascites due to hypothyroidismAlan S Sacerdote, Gul Bahtiyar, Jaydira Del Rivero
JCO Oncology Practice|September 29, 2023
Systemic Therapy for Tumor Control in Well-Differentiated Metastatic Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline Q and AJaydira Del Rivero, Erin B Kennedy, Kimberley Perez
Cancers|July 29, 2023
Grade Progression and Intrapatient Tumor Heterogeneity as Potential Contributors to Resistance in Gastroenteropancreatic Neuroendocrine TumorsDiana Grace Varghese, Jaydira Del Rivero, Emily Bergsland
Current Treatment Options in Oncology|August 31, 2020
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and ParagangliomaMaran Ilanchezhian, Abhishek Jha, Karel Pacak, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 17, 2020
Update on the Treatment of Medullary Thyroid Carcinoma in Patients with Multiple Endocrine Neoplasia Type 2Maran Ilanchezhian, Sophia Khan, Christian Okafor, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|January 29, 2025
Systemic therapy for patients with metastatic pheochromocytoma and paragangliomaAlessa Fischer, Jaydira Del Rivero, Katharina Wang, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Oncology (Williston Park, N.Y.)|April 17, 2017
PARP Inhibitors: The Cornerstone of DNA Repair-Targeted TherapiesJaydira del Rivero, Elise C Kohn
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 13, 2015
Invited commentaryJaydira Del Rivero, Steven K Libutti
JAMA Oncology|November 8, 2019
Neuroendocrine Tumors-Less Well Known, Often Misunderstood, and Rapidly Growing in IncidenceAman Chauhan, Elise Kohn, Jaydira Del Rivero
Translational Lung Cancer Research|February 3, 2017
Metastatic lung cancer in the age of targeted therapy: improving long-term survivalJaydira Del Rivero, Lindsey Enewold, Anish Thomas
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 16, 2010
Visual vignette. Ascites due to hypothyroidismAlan S Sacerdote, Gul Bahtiyar, Jaydira Del Rivero
JCO Oncology Practice|September 29, 2023
Systemic Therapy for Tumor Control in Well-Differentiated Metastatic Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline Q and AJaydira Del Rivero, Erin B Kennedy, Kimberley Perez
Cancers|July 29, 2023
Grade Progression and Intrapatient Tumor Heterogeneity as Potential Contributors to Resistance in Gastroenteropancreatic Neuroendocrine TumorsDiana Grace Varghese, Jaydira Del Rivero, Emily Bergsland
Current Treatment Options in Oncology|August 31, 2020
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and ParagangliomaMaran Ilanchezhian, Abhishek Jha, Karel Pacak, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 17, 2020
Update on the Treatment of Medullary Thyroid Carcinoma in Patients with Multiple Endocrine Neoplasia Type 2Maran Ilanchezhian, Sophia Khan, Christian Okafor, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|January 29, 2025
Systemic therapy for patients with metastatic pheochromocytoma and paragangliomaAlessa Fischer, Jaydira Del Rivero, Katharina Wang, et al.
Pageof 13